The Pennant Group, Inc. (PNTG) Surpasses Q1 Earnings and Revenue Estimates

Core Viewpoint - The Pennant Group, Inc. reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.22 per share, and showing an increase from $0.20 per share a year ago, indicating a positive earnings surprise of 22.73% [1] Financial Performance - The company achieved revenues of $209.84 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.68%, and up from $156.92 million year-over-year [2] - Over the last four quarters, The Pennant Group has exceeded consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Performance - The Pennant Group shares have increased by approximately 0.8% since the beginning of the year, contrasting with the S&P 500's decline of -3.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.26 on revenues of $206.89 million, and for the current fiscal year, it is $1.08 on revenues of $832.9 million [7] Industry Outlook - The Medical - Outpatient and Home Healthcare industry, to which The Pennant Group belongs, is currently ranked in the top 18% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5][6]